After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Inari Medical Inc is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $41.88 and fluctuated between $42.53 as its day high and $41.24 as its day low. The current market capitalization of Inari Medical Inc is $2.43B. A total of 0.84 million shares were traded on the day, compared to an average of 857.38K shares.
In the most recent transaction, Hoffman William sold 25,000 shares of NARI for 65.08 per share on Dec 15 ’23. After the transaction, the Director now owns 1,045,493 company shares. In a previous transaction on Dec 12 ’23, Hill, Mitch C. sold 6,500 shares at 62.75 per share. NARI shares that Chief Financial Officer owns now total 170,230.
Among the insiders who sold shares, Hykes Andrew disposed of 37,448 shares on Nov 16 ’23 at a per-share price of $59.82. This resulted in the President and CEO holding 434,817 shares of NARI after the transaction. In another insider transaction, Tu Thomas sold 25,451 shares at $59.82 per share on Nov 16 ’23. Company shares held by the Chief Medical Officer now total 320,932.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NARI has a high of $71.85 and a low of $40.81.
As of this writing, NARI has an earnings estimate of -$0.2 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.39.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NARI’s latest balance sheet shows that the firm has $176.10M in Cash & Short Term Investments as of fiscal 2021. There were $29.21M in debt and $42.51M in liabilities at the time. Its Book Value Per Share was $8.05, while its Total Shareholder’s Equity was $239.21M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NARI is Buy with a score of 4.44.
